The School of Pharmacy has been ranked in the top three of over 100 schools nationally for NIH funding (NIH funding per PhD FTE ) since 2002 by the American Association of Colleges of Pharmacy (AACP) and is routinely ranked as one of the most productive units on the Anschutz Medical Campus.
Research is conducted in both the Department of Clinical Pharmacy and the Department of Pharmaceutical Sciences.
Department of Clinical Pharmacy
In addition to teaching the next generation of pharmacists and providing exemplary patient care, faculty in the Department of Clinical Pharmacy (DOCP) are also highly engaged in research designed to enhance the safe and effective use of drugs and to assess patient outcomes associated with medication use. DOCP faculty conduct clinical research across a wide range of therapeutic areas including oncology, neurology, diabetes, cardiovascular diseases, geriatric medicine, critical care, infectious diseases, and others. The department is also currently developing a new Center for Pharmaceutical Outcomes Research to enhance research in areas such as pharmacoeconomics and cost-effectiveness analysis, pharmacoepidemiology, health policy research, and pharmacy benefits design.
Department of Pharmaceutical Sciences
The Department of Pharmaceutical Sciences (DOPS) consists of an outstanding and collegial group of staff, students, fellows and faculty and all contribute to the considerable success the department has enjoyed in the research arena. We invest heavily in research and attempt to optimize communication between researchers using a number of mechanisms including a two day off-campus research retreat. To give some sense of the size of the research operation within the department, the attendees at the 2010 departmental retreat numbered 137. An overview of research areas in DOPS is given below with a link to more detailed descriptions. Individual faculty pages describe research interests in much greater detail. Research in DOPS is focused in four integrated areas (Figure 1). DOPS continues to build in its core areas of Pharmaceutical Biotechnology, Biophysics, Toxicology and Cancer Pharmacology while pursuing new initiatives in Clinical and Translational Sciences, Medicinal Chemistry and Drug Discovery.
Figure 1 – the figure – below provides a snapshot of the department. More in-depth information is available on the DOPS Research Area page.